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Introduction
Irritable bowel syndrome (IBS) is a common chronic func-
tional bowel disease. Its main features include abdominal 
pain, changes in defecation, abnormal stool and a lack of 
significant organic changes. An epidemiological study has 
shown the global prevalence of IBS to be 11.2%.1 Current 
therapeutic methods mainly include medicinal, psychologi-
cal and dietary therapy.2 However, medicinal therapy is 
limited to symptomatic treatment and is associated with 
certain side effects. Furthermore, the long-term effects are 
unsatisfactory. Acupuncture has been used as a safe and 
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Background: Moxibustion treatment has been found to ameliorate clinical symptoms including abdominal pain, diar-
rhoea and constipation in patients with irritable bowel syndrome (IBS). Herein we investigated the mechanisms underly-
ing the use of moxibustion in a rat model of IBS.
Methods: In our study, an IBS model was established in rats by colorectal distension (CRD) stimulus and mustard oil 
enema. The rats were randomly divided into a normal group, model group, mild moxibustion group, electroacupuncture 
group, probiotic group and dicetel group. Abdominal withdrawal reflex (AWR) scores were determined within 90 min 
of the last treatment. The expression of GDNF/GFRα3 protein and mRNA in the colon and spinal cord were detected 
by immunohistochemistry and quantitative real-time-PCR, respectively.
Results: The IBS model rats had significantly higher AWR scores than the normal group (P<0.01). After mild moxibustion 
treatment, the AWR score was significantly reduced (20 mm Hg, P<0.05; 40 mm Hg, 60 mm Hg and 80 mm Hg, P<0.01). 
The model group showed significantly more colonic glial cell line-derived neurotrophic factor (GDNF/GFRα3 (GDNF fam-
ily receptor α3) protein and mRNA expression in the colon and spinal cord than the normal group (P<0.01). Compared 
with the model group, the expression of GDNF/GFRα3 protein and mRNA in the colon and spinal cord of the rats were 
significantly decreased in the mild moxibustion group (colon: GDNF and GFRα3 protein, P<0.01; GDNF and GFRα3 
mRNA, P<0.01; spinal cord: GDNF and GFRα3 protein, P<0.01; GDNF mRNA, P<0.05, GFRα3 mRNA, P<0.01).
Conclusions: Our data suggest that moxibustion therapy may mitigate CRD-induced increases in the expression of 
GDNF and its receptor GFRα3 in the colon and spinal cord in a rat model of IBS.
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effective therapy to treat IBS and related functional bowel 
disorders.3,4 It not only mitigates clinical symptoms, includ-
ing abdominal pain, diarrhoea and constipation, but also 
regulates intestinal substance P, vasoactive intestinal pep-
tides and expression of the P2x7 receptor.5,6
The pathogenesis of IBS has not been fully characterised. 
Recent studies indicate that it might be associated with brain–
gut interactions, visceral hypersensitivity, colonic dysmotility, 
and genetic and psychological factors.7,8 In recent years, studies 
have indicated that visceral hypersensitivity is the main cause of 
abdominal pain and diarrhoea in patients with IBS.9 Reducing 
visceral hypersensitivity and relieving clinical symptoms in IBS 
patients are important therapeutic strategies. Glial cell line-
derived neurotrophic factor (GDNF) is a neurotrophic factor 
with several biological activities. Studies have shown that the 
visceral hypersensitivity rat model has a high expression of 
GDNF.10 Tanaka et al. found a high expression of GDNF in the 
dorsal root ganglia of the visceral hypersensitivity rat model.11 
Moxibustion is an effective method for treating IBS.12,13 In this 
study, we focused on visceral hypersensitivity and GDNF/
GFRα3 (GDNF family receptor α3) to investigate the mecha-
nism of action underlying the effects of moxibustion on IBS.
Methods
Animals
Sixty male Sprague-Dawley rat pups were obtained 8 days 
after birth from the Experimental Animal Center, Shanghai 
University of Traditional Chinese Medicine. The laboratory 
temperature was 22±2°C and humidity was 60±5%. All 
experimental procedures were performed according to the 
protocols approved by the University Animal Care and Use 
Committee of Shanghai University of Traditional Chinese 
Medicine (IACUC protocol no. SYXK (Shanghai) 2009–
0082) and in accordance with the National Institutes for 
Health (NIH) ‘Guide for the Care and Use of Laboratory 
Animals’ to reduce pain and to avoid harm.
Model establishment
The number of rats was based on the power calculation of a 
previous study.14 According to a random number table gener-
ated by SPSS version 21.0, 10 rats were selected as a normal 
group. According to the protocol described by Al-Chaer et al.,15 
the remaining 50 rats formed the model group and received 
colorectal distension (CRD) via balloon stimulation, which is 
one of the most widely used methods to induce visceral hyper-
sensitivity,16 on a daily basis between the age of 8 and 21 days. 
A 3 cm balloon stimulator was connected to a 10 cm long latex 
tube. At the end of the tube, a Y connector was attached to a 
syringe and sphygmomanometer, which provided constant 
dilation pressure and stimulation. The balloon stimulator was 
first lubricated with petrolatum and inserted into the rat colon in 
line with its physiological curvature. The balloon was inserted 
2 cm deep to the anus and then inflated with 0.5 mL air for 1 
min; this was repeated after 1 hour and again once a day for 14 
consecutive days. After the daily procedure was finished, the 
rats were put back into the cages with their mothers. After 4 
weeks rest, the model rats then received colonic injections of 
0.2 mL 4% mustard oil once a day for 14 consecutive days. The 
abdominal withdrawal reflex (AWR) was tested by different 
observers. The model was considered successfully established 
when the AWR score in model rats was significantly greater 
than that of the normal rats.
Grouping and processing
The rats were randomly divided into the following groups:
Normal group (NG) and Model (CRD) groups: No 
treatment.
Mild moxibustion group (CRD+MM): Mild moxibustion 
(MM) was applied at bilateral ST25 (Tianshu) and ST37 
(Shangjuxu). Special fine moxa sticks used for this experi-
ment were 4 mm in diameter and 12 cm in length, and were 
provided by the Nanyang Hanyi Moxa factory in China. The 
moxibustion was performed 2–3 cm above the traditional 
acupuncture points for 10 min, once a day for 7 days.
Electroacupuncture group (CRD+EA): Sterilised stain-
less steel acupuncture needles (Yunlong, Wujiang Yunlong 
Medical Instruments Factory, Wujiang, China) 25 mm in 
length and 0.3 mm in diameter were inserted to a depth of 
about 2–3 mm at ST25 and ST37 bilaterally. An electrical 
acupuncture point stimulator (HAN-200A, Jisheng Ltd, 
Beijing, China) was used to stimulate the needles using dila-
tational waves (2–100 Hz, intensity 1mA). Each treatment 
was performed for 20 min once per day for 7 days in total.
Probiotic group (CRD+PB): Bifidobacteria Triple 
Viable (SFDA approval no. S19980004) was administrated 
via oral gavage. Daily dosage was calculated according to 
the ratio between adult humans (70 kg body weight) and 
rats (200 g body weight), which was 1:0.018 (based on the 
Methods for Pharmaceutical Experiment). The treatment 
was performed once a day for 7 days in total.
Dicetel group (CRD+DG): Dicetel (SFDA approval no. 
H20120127) was administrated via oral gavage. The same 
dosing and timing as the Probiotic group were applied.
One rat died during the preparation of the model, two 
rats in the CRD+PB group and two rats in the 
CRD+DG group died after gavage, and three rats died for 
unknown reasons. The final number of rats in each group 
were: NG, n=8; CRD, n=8; CRD+MM, n=8; CRD+EA, 
n=8; CRD+PB, n=6; and CRD+DG, n=7.
Sample collection and processing
After treatment, all rats were weighed and anaesthetised 
with 2% pentobarbital sodium (2 ml/kg), and then eutha-
nased by cervical dislocation. Spinal cords (L6–S2) and 
colonic samples (2–3 cm) from the distal colon were 
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collected immediately. The samples were stored at −80°C 
for immunohistochemistry and real-time PCR analysis.
AWR scoring
Within 90 min of the last treatment, the AWR score was cal-
culated according to Al-Chaer et al.15 Balloon dilation pres-
sures had four pressure grades: 20, 40, 60 and 80 mm Hg. 
Each distension stimulation lasted about 20 s and was 
repeated three times. The average of the scores for each rat 
was used for statistical analysis. The AWR scoring stand-
ards applied were as follows: no reaction to the colorectal 
balloon dilation stimulation, score 0; a motion stop and a 
brief head movement, score 1; abdominal muscle contrac-
tion but without abdominal lifting, score 2; abdominal lift-
ing and lifting off the platform, score 3; arching of body 
and lifting of pelvis and scrotum, score 4.
Immunohistochemical analysis of GDNF and 
its receptor GFRα3
Formalin-fixed paraffin-embedded sections (4 μm thick) were 
immunostained using anti-GDNF (ab18956, 1:100, Abcam) 
and anti-GFRα3 (ab8028, 1:100, Abcam) antibodies accord-
ing to the manufacturer’s instructions. The primary antibodies 
were added and incubated at 4°C overnight, and the corre-
sponding secondary antibodies (BA1003, 1:150, Wuhan 
Boster Biological Technology Co Ltd) were added and incu-
bated at room temperature for 1 hour. After DAB reaction for 
3–5 min, the sections underwent 2 min of haematoxylin stain-
ing and were then viewed under an optical microscope.
Using Image-Plus Pro image analysis software, three 
randomly selected sections were counted from each rat per 
group and analysed for the average optical density of the 
positive target.
Real-time quantitative PCR analysis of 
GDNF and its receptor GFRα3
Total RNA was extracted using TRIzol LS (Invitrogen Corp) 
according to the manufacturer’s instructions. The PCR reac-
tion mixture (16 μL) comprised 5 μl of H2O, 8 μl of 2×SYBR 
Green PCR mix, 1 μl of upstream primer (10 pm/μl), 1 μl of 
downstream primer (10 pm/μl) and 1 μl of reverse transcrip-
tion product (cDNA). Reaction conditions were as follows: 
95°C for 2 min, 94°C for 10 s, 60°C for 10 s and 72°C for 
40 s, 40 cycles. The sequences of the target genes were set 
according to the Gene Bank database. Primers were designed 
using ABI Primer Express Software v 2.0 and synthesised by 
BGI Inc. The primer sequences were as follows:
GAPDH: upstream 5′-GGCAAGTTCAACGGCACAG 
T-3′; downstream 5′-ATGACATACTCAGCACCGGC-3′.
GDNF: upstream 5′-TCGAAGAGAGAGGAACCGG 
C-3′; downstream 5′-TTAAGACGCACCCCCGATTT-3′.
GFRα3: upstream 5′-AAAATGCGAGGCTAATCCCG 
-3′ downstream 5′-CTTCAAGGCACGCTGCAGAT-3′.
Relative mRNA expression of the target genes was cal-
culated using the 2-ΔΔCt method: target gene ΔCt=target gene 
Ct − reference (GAPDH) Ct, ΔΔCt=target gene Ct − aver-
age of blank ΔCt.
Statistical analysis
Statistical analysis was performed using SPSS 21.0 (IBM Co, 
Armonk, NY, USA). Data were expressed as mean±SD 
( x s± ) for normal distribution and analysed using one-way 
analysis of variance (ANOVA). When the variance was 
homogeneous, the least significant difference (LSD) was 
used; otherwise, the Games-Howell method was used. Data 
were expressed as median (range) for non-normally distrib-
uted data and analysed using the rank-sum test. Differences 
were considered statistically significant when P<0.05.
Results
AWR score
The average stimulation score of the CRD group was sig-
nificantly higher than that of the normal group (P<0.01). 
The various treated groups showed lower AWR scores than 
the CRD group in response to different stimulation intensi-
ties. Among them, the AWR scores of the CRD+MM group 
were significantly reduced (20 mm Hg, P<0.05; 40, 60 and 
80 mm Hg, P<0.01); AWR scores of the CRD+MM group 
under 60 and 80 mm Hg were significantly lower than in 
the CRD+PB and CRD+DG groups (CRD+PB group: 
60 mm Hg, P<0.05, 80 mm Hg, P<0.01; CRD+DG group: 
60 mm Hg, P<0.01, 80 mm Hg, P<0.05) (Figure 1).
Protein expression of GDNF and GFRα3 in 
the colon
The CRD group showed significantly more colonic GDNF 
and GFRα3 protein expression than the normal group 
(P<0.01). The CRD+MM, CRD+EA, CRD+PB and 
CRD+DG groups all showed significantly less GDNF protein 
expression than the CRD group (CRD+MM, CRD+EA and 
CRD+DG groups, P<0.01; CRD+PB group, P<0.05). The 
CRD+MM, CRD+EA, CRD+PB and CRD+DG groups 
also showed significantly less GFRα3 protein expression than 
the CRD group (P<0.01). Compared with the 
CRD+MM group, protein expression of GFRα3 was higher 
in the CRD+PB and CRD+DG groups (P<0.01) (Figure 2).
Protein expression of GDNF and GFRα3 in 
the spinal cord
The CRD group showed significantly more GDNF and 
GFRα3 protein expression than the normal group (P<0.01). 
The CRD+MM, CRD+EA, CRD+PB and CRD+DG 
groups all showed significantly less GDNF and GFRα3 pro-
tein expression than the CRD group (P<0.01) (Figure 3).
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mRNA expression of GDNF and GFRα3 in 
the colon
Compared with the normal group, the CRD group showed a 
significant increase in colonic GDNF and GFRα3 mRNA 
expression (P<0.01). Compared with the CRD group, the 
CRD+MM, CRD+EA, CRD+PB and CRD+DG groups 
all showed a significant decrease in colonic GDNF mRNA 
expression (P<0.01). The CRD+MM, CRD+EA, 
CRD+PB and CRD+DG groups also showed a significant 
decrease in colonic GFRα3 mRNA expression (CRD+MM, 
CRD+EA and CRD+DG groups, P<0.01; CRD+PB group, 
P<0.05) compared with the CRD group (Figure 4).
mRNA expression of GDNF and GFRα3 in 
the spinal cord
The CRD group showed significantly more GDNF and 
GFRα3 mRNA expression in the spinal cord than the normal 
group (P<0.01). The CRD+MM, CRD+EA, CRD+PB 
and CRD+DG groups all showed a significant decrease in 
GDNF mRNA expression in spinal cord (CRD+MM group, 
P<0.05; CRD+PB, CRD+EA and CRD+DG groups, 
P<0.01). The CRD+MM, CRD+EA, CRD+PB and 
CRD+DG groups also showed significantly less GFRα3 
mRNA expression than the CRD group (P<0.01) (Figure 5).
Discussion
In our experiments, the AWR score was adopted to evaluate 
intestinal sensitivity. We found that the AWR score in the CRD 
group was significantly higher than in the normal group, indi-
cating that visceral hypersensitivity in IBS rats plays an impor-
tant role in the pathogenesis of the condition, which is consistent 
with previous findings.17 Visceral hyperalgesia may be the result 
of a combination of peripheral and central sensitisation mecha-
nisms. The enteric nervous system (ENS), spinal cord and cen-
tral nervous system (CNS) are involved in the occurrence of 
visceral sensation. Studies have demonstrated that the ENS con-
tributes to visceral hypersensitivity.18 Therefore, it is likely that 
GDNF in the ENS is also involved in the formation of visceral 
Figure 1. Abdominal withdrawal reflex (AWR) scores under different distension pressures (A: 20 mm Hg, B: 40 mm Hg, 
C: 60 mm Hg, D: 80 mm Hg) in different groups (Normal group: NG, n=8; Model group: CRD, n=8; Mild moxibustion group: 
CRD+MM, n=8; Electroacupuncture group: CRD+EA, n=8; Probiotic group: CRD+PB, n=6; Dicetel group: CRD+DG, n=7). 
*P<0.01 versus NG; P<0.05, P<0.01 versus CRD; #P<0.05, ■ P<0.01 versus CRD+MM.
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hypersensitivity. In view of this, we observed the expression of 
GDNF and its receptor GFRα3 in the colon and spinal cord.
Studies have shown that acupuncture and moxibustion can 
regulate gastrointestinal function and relieve visceral hyperalge-
sia, and exert their therapeutic effect mainly by regulating, 
abnormally expressed 5-HT, TRPV1 and HSP70.19,20 In this 
study, AWR score was significantly decreased in the CRD+MM, 
CRD+EA, CRD+PB and CRD+DG groups compared with 
the CRD group, indicating that moxibustion can 
effectively alleviate visceral hypersensitivity in IBS rats as well 
as probiotics and dicetel. Under 60 and 80 mm Hg, the AWR 
score in the CRD+MM group was significantly lower than the 
CRD+PB and CRD+DG groups, indicating that moxibustion 
may be more beneficial at reducing IBS rat visceral pain. Recent 
studies have shown that electroacupuncture,21 probiotic22 and 
dicetel23 have good effects in the treatment of IBS. Our results 
suggest that moxibustion may potentially be used as an alterna-
tive treatment to probiotics and dicetel.
Figure 2. Representative immunohistochemistry images taken at ×400 magnification and mean integral optical density 
(IOD) in the colon (A: GDNF; B: GFRα3). Normal group: NG, n=8; Model group: CRD, n=8; Mild moxibustion group: 
CRD+MM, n=8; Electroacupuncture group: CRD+EA, n=8; Probiotic group: CRD+PB, n=6; Dicetel group: CRD+DG, 
n=7. Results are IOD of three visual fields per rat per group (mean±SD). Arrows indicate positive expression of GDNF or 
GFRα3. *P<0.01 versus NG; P<0.05, P<0.01 versus CRD; #P<0.05, ■ P<0.01 versus CRD+MM.
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GDNF can be used to treat diseases of the CNS such as 
Alzheimer’s disease and Parkinson’s disease.24,25 In this way, 
GDNF and its receptor GFRα3 are critical to maintaining the 
CNS and ENS. Therefore, GDNF and GFRα3 are likely to 
play a role in intestinal inflammation. Our study has shown 
that the expression of GDNF and GFRα3 in the colon of the 
IBS model rats were higher than in the normal group. It is 
implicated that the need of neurons and glial cells for GDNF 
and GFRα3 was increased, suggesting that GDNF and 
GFRα3 play a protective and promotional role in the regen-
eration of enteric neurons, are involved in the regulation of 
intestinal inflammatory processes, and may have a role in 
promoting recovery of the intestinal mucosa in IBS.
In this study, we also found that, compared with the rats 
in the normal group, the expression of GDNF and GFRα3 
in the spinal cord of rats in the CRD group was increased. 
Similar to the results reported here, previous studies have 
also indicated that GDNF is upregulated in IBS patients.26 
Figure 3. Representative immunohistochemistry images taken at ×400 magnification and the mean integral optical 
density (IOD) in spinal cord (A: GDNF; B: GFRα3). Normal group: NG, n=8; Model group: CRD, n=8; Mild moxibustion 
group: CRD+MM, n=8; Electroacupuncture group: CRD+EA, n=8; Probiotic group: CRD+PB, n=6; Dicetel group: 
CRD+DG, n=7. Results are IOD of three visual fields per rat per group (mean±SD). Arrows indicate positive 
expression of GDNF or GFRα3. *P<0.01 versus NG; P<0.05, P<0.01 versus CRD; #P<0.05, ■ P<0.01 versus 
CRD+MM.
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Compared with the CRD group, the CRD+MM group 
showed a reduced expression of GDNF and GFRα3 in the 
colon and spinal cord. This suggests that moxibustion ther-
apy may regulate the increased expression of GDNF and 
GFRα3 in the colon and spinal cord of IBS rats. Studies 
have shown that moxibustion can regulate intestinal 
inflammation to treat inflammatory bowel disease.27 Based 
on the results of our study, it is possible that moxibustion 
causes the enteric glial cells to secrete GDNF by regulat-
ing intestinal inflammation. Consequently, it may alleviate 
visceral hypersensitivity, reduce the pain threshold and 
relieve visceral pain. However, the exact mechanism 
requires further study.
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